/Edwards%20Lifesciences%20Corp%20logo%20on%20phone-%20by%20IgorGolovniov%20via%20Shutterstock.jpg)
Irvine, California-based Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. It is valued at a market cap of $45.9 billion.
This healthcare company has considerably underperformed the broader market over the past 52 weeks. Shares of EW have gained 7.8% over this time frame, while the broader S&P 500 Index ($SPX) has soared 26.6%. Moreover, on a YTD basis, the stock is down 4.5%, compared to SPX’s 8.1% rise.